Monomethyl Fumarate, also known by its synonym Fumaric Acid Monomethyl Ester, is a chemical compound recognized for its utility in the pharmaceutical sector. With the CAS number 2756-87-8, this substance plays a critical role as a pharmaceutical intermediate, particularly in the synthesis of advanced therapeutic agents. This article focuses on the tangible properties of Monomethyl Fumarate, its sourcing, and why understanding these details is paramount for any organization involved in chemical synthesis and drug manufacturing. We'll explore its physical form, purity levels, and the strategic advantage of procuring this chemical.

The physical characteristics of Monomethyl Fumarate are key to its identification and application. It is supplied as a white crystalline powder, indicating a solid form with a defined crystal structure. This appearance is a primary indicator of purity and consistency, which are non-negotiable aspects when dealing with pharmaceutical precursors. The compound's molecular formula, C5H6O4, and molecular weight, 130.10, provide fundamental chemical identification. Its melting point, a critical quality control parameter, is consistently reported between 144-145°C. This narrow melting range suggests a high degree of purity, a vital attribute for any pharmaceutical intermediate used in sensitive synthesis processes. For businesses sourcing this material, this data is crucial for process validation and ensuring batch-to-batch reproducibility.

The significance of Monomethyl Fumarate is amplified by its specific role in the synthesis of Neratinib, a medication used in cancer therapy. Neratinib requires precise precursors to achieve its therapeutic efficacy, and Monomethyl Fumarate serves as one such essential building block. The demand for high-purity intermediates like Monomethyl Fumarate is driven by the rigorous standards of the pharmaceutical industry. Ensuring a reliable supply chain for chemicals with such specific applications is a constant challenge for R&D departments and production facilities alike. This makes understanding the sourcing of CAS 2756-87-8 from trusted manufacturers, such as those operating as a supplier in China, a strategic imperative.

The assay or purity level of Monomethyl Fumarate is typically specified as being greater than or equal to 98.0%. This high purity is essential for minimizing side reactions and ensuring the successful synthesis of the target pharmaceutical product. Impurities in intermediates can lead to lower yields, more complex purification steps, and potentially compromised final drug quality, which is unacceptable in pharmaceutical manufacturing. Therefore, meticulous attention to the purity of chemical intermediates is a hallmark of quality-driven pharmaceutical production.

In conclusion, Monomethyl Fumarate (CAS: 2756-87-8) is a vital compound whose properties directly impact the success of advanced pharmaceutical syntheses. Its physical form as a white crystalline powder, its defined melting point, and its high purity level of ≥98.0% make it an ideal intermediate for applications like Neratinib synthesis. For organizations requiring this chemical, securing a reliable supply from manufacturers who prioritize quality and consistency is crucial. As a key pharmaceutical intermediate, Monomethyl Fumarate exemplifies the importance of precise chemical sourcing in the drug development lifecycle.